Genmab A/S Says Baillie Gifford & Co Held The Voting Rights To 3,301,530 Shares In Genmab A/S, Which Amounts To 4.99% Of The Share Capital And Voting Rights As Of October 3, 2024

Benzinga · Oct 5 01:59

Major shareholder announcement for Genmab A/S

COPENHAGEN, Denmark; October 4, 2024 – Genmab A/S (NASDAQ:GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Baillie Gifford & Co has informed us that, as of October 3, 2024, Baillie Gifford & Co held the voting rights to 3,301,530 shares in Genmab A/S, which amounts to 4.99% of the share capital and voting rights in Genmab A/S.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Genmab A/S Says Baillie Gifford & Co Held The Voting Rights To 3,301,530 Shares In Genmab A/S, Which Amounts To 4.99% Of The Share Capital And Voting Rights As Of October 3, 2024

Risk Disclaimer